Dataset from Weighing Risks and Benefits of Laparoscopic Anti-Reflux Surgery in Patients With Idiopathic Pulmonary Fibrosis

This study will test the hypothesis that treatment with laparoscopic anti-reflux surgery in subjects with idiopathic pulmonary fibrosis (IPF) and abnormal gastroesophageal reflux (GER) will slow the decline of forced vital capacity (FVC) over 48 weeks.

本研究将验证下述假说：针对特发性肺纤维化（idiopathic pulmonary fibrosis, IPF）合并异常胃食管反流（gastroesophageal reflux, GER）的受试者，采用腹腔镜抗反流手术治疗，可在48周内延缓用力肺活量（forced vital capacity, FVC）的下降。